Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe!
Amylin to be led by former Novartis exec – Amylin Pharmaceuticals has taken another step forward in its long & storied history. The company has announced that former Novartis executive Paulo Costa will become its new chairman…more
An interesting lawsuit: individual suing Celgene for blockbuster drug idea – In 1996, Beth Jacobson was watching her husband, a 35-year-old cardiologist, die from the blood cancer multiple myeloma…more
Gene variation impacts 1/3 of Plavix patients? – A common gene variation explains why many people are not helped by the widely prescribed blood thinner Plavix, U.S. researchers said on Tuesday in a study confirming earlier research and paving the way for tests to screen patients before they get the drug…more
From the rumor mill – Glaxo eyeing Human Genome Sciences? And, is B-I cutting a major percentage of its sales force in the U.S.? (can anyone confirm or deny with facts?)
Corporate HR workshops – Sexual Harassment. Compliance. Communications. Ethics. Diversity. The Impactiviti Partner Network has what you need. Contact me (stevew at impactiviti dot com, or phone at 973-947-7429) for information and recommendations!
Are placebos getting more effective? What’s going on here? – From 2001 to 2006, the percentage of new products cut from development after Phase II clinical trials, when drugs are first tested against placebo, rose by 20 percent. The failure rate in more extensive Phase III trials increased by 11 percent, mainly due to surprisingly poor showings against placebo…more
JUST FOR FUN
Who’s got the better colors? An eye-popping series of 3 photos you’ll enjoy!
Subscribe to the Impactiviti blog via e-mail
Connect with Steve Woodruff